Frequently Asked Questions about AbbVie Inc. (ABBV)

Name: AbbVie Inc. (ABBV) Institutional Financial Dataset
Creator: Olyth
License: https://olyth.xyz

Question 1

What does AbbVie Inc. (ABBV) do?

Accepted Answer

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for th...

Question 2

Is AbbVie Inc. (ABBV) a good stock to buy?

Accepted Answer

Olyth's institutional analysis of ABBV reveals an Altman Z-Score of 2.00 and a Piotroski F-Score of 8/9. These metrics, combined with its 5-year revenue trend ($61.16B most recent), help investors decide if ABBV fits their risk profile.

Question 3

What is the current P/E ratio for ABBV?

Accepted Answer

As of the latest trading session, AbbVie Inc. (ABBV) has a trailing P/E ratio of 87.06.

Question 4

Who is the CEO of AbbVie Inc.?

Accepted Answer

The current Chief Executive Officer of AbbVie Inc. is Scott T. Reents.

Question 5

What was ABBV's revenue for the last 5 years?

Accepted Answer

According to its latest income statements, AbbVie Inc. reported annual revenues of $61.16B (2025), $56.33B (2024), $54.32B (2023), $58.05B (2022), $56.20B (2021) respectively.

Question 6

Does ABBV pay a dividend?

Accepted Answer

AbbVie Inc. currently pays a dividend to its shareholders, with a trailing dividend yield of 3.22%.

Question 7

How much debt and cash flow does ABBV have?

Accepted Answer

In its latest reporting period, AbbVie Inc. generated $17.82B in Free Cash Flow against a total debt load of $69.07B.

Question 8

What is the Price-to-Book (P/B) ratio of AbbVie Inc.?

Accepted Answer

The Price-to-Book (P/B) ratio for AbbVie Inc. (ABBV) is currently -112.51.

Question 9

What is the Price-to-Sales (P/S) ratio of ABBV?

Accepted Answer

Based on trailing twelve-month data, AbbVie Inc. (ABBV) trades at a Price-to-Sales (P/S) ratio of 5.97.

Question 10

What is AbbVie Inc.'s Return on Equity (ROE)?

Accepted Answer

AbbVie Inc. (ABBV) has a Return on Equity (ROE) of -361.58%, representing its profitability relative to shareholder equity.

Period	Total Assets	Total Liabilities	Total Equity	Total Debt	Net Debt
2025-12	134B	137.2B	-3.2B	69.1B	63.8B
2024-12	135.2B	131.8B	3.4B	67.8B	62.3B
2023-12	134.7B	124.3B	10.4B	60.1B	47.3B
2022-12	138.8B	121.5B	17.3B	64.2B	55B
2021-12	146.5B	131.1B	15.4B	77.6B	67.8B

Period	Total Assets	Total Liabilities	Total Equity	Total Debt	Net Debt
2025-12	134B	137.2B	-3.2B	69.1B	63.8B
2024-12	135.2B	131.8B	3.4B	67.8B	62.3B
2023-12	134.7B	124.3B	10.4B	60.1B	47.3B
2022-12	138.8B	121.5B	17.3B	64.2B	55B
2021-12	146.5B	131.1B	15.4B	77.6B	67.8B